SpyGlass Pharma, Inc. (SGP) Live Share Price, Invest From India

SpyGlass Pharma, Inc. Stock Performance

as on May 13, 2026 at 6:59 am IST

Day's Low
Day's High
$23.41
Day's Price Range
$24.35
$24.19
3.22%
Downside
0.66%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$24.19
100.00%
Downside
-100.00%
Upside

SpyGlass Pharma, Inc. share price movements today

Previous Close: $23.76
Open: $23.59
Volume: 150.3K
Day's Low - High: $23.41 - $24.35

SpyGlass Pharma, Inc. Historical Returns

1 Month Return: + 14.51 %
3 Month Return: -13.6 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

SpyGlass Pharma, Inc. Stock Fundamentals & Key Indicators

Check SpyGlass Pharma, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$782.5M

EPS (TTM)

-1.6449

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-67.71%

SpyGlass Pharma, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of SpyGlass Pharma, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
SpyGlass Pharma, Inc.	NA	$782.5M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$39.4B	113.59%	74.13	12.55%
BeiGene, Ltd.	NA	$32.2B	NA	70.46	8.94%
Vertex Pharmaceuticals Inc	BUY	$109.1B	104.61%	25.51	35.51%
Regeneron Pharmaceuticals Inc	BUY	$74.9B	40.55%	17.45	29.65%

Indian Investors' Interest in SpyGlass Pharma, Inc. Stock

Search interest for SpyGlass Pharma, Inc. Stock has increased by 24% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 13, 2026 to May 13, 2026

Change:24% versus previous 30 day period

SpyGlass Pharma, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2024	Dec 2025
Total Revenue	-	-
Gross Profit	-	-
Operating Income	-7	-13
EBITDA	-	-
Interest Expense	-	-
Depreciation	0	0
Income Before Tax	-8	-12
Income Tax Expense	-	-
Net Income	-8	-12
Net Profit Margin	0.00%	0.00%

SpyGlass Pharma, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-
Gross Profit	-	-	-
Operating Income	-14	-27	-41
EBITDA	-	-	-
Interest Expense	-	-	-
Depreciation	0	0	0
Income Before Tax	-13	-29	-39
Income Tax Expense	-	-	-
Net Income	-13	-29	-39
Net Profit Margin	0.00%	0.00%	0.00%

SpyGlass Pharma, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Dec 2025
Net Income	-12
Operating Cash Flow	-9
Investing Cash Flow	-
Financing Cash Flow	0
Change in Cash	-9

SpyGlass Pharma, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2024	Dec 2025
Net Income	-29	-39
Operating Cash Flow	-22	-32
Investing Cash Flow	-	-
Financing Cash Flow	0	124
Change in Cash	0	80

Insights on SpyGlass Pharma, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NEGATIVE IMPACT
Price Dip
In the last 7 days, SGP stock has moved down by -5.2%

About SpyGlass Pharma, Inc.

SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including novel and proprietary drug pads attached to an intraocular lens (IOL), which is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) in patients. It also develops a non-IOL-based, ring-shaped, sustained-release implant with bimatoprost. SpyGlass Pharma, Inc. was formerly known as SpyGlass Ophthalmics, Inc. and changed its name to SpyGlass Pharma, Inc. in April 2021. The company was incorporated in 2019 and is based in Aliso Viejo, California.

Organisation	SpyGlass Pharma, Inc.
Headquarters	27061 Aliso Creek Road, Aliso Viejo, CA, United States, 92656
Industry	Biotechnology
CEO	Mr. Patrick H. Mooney
E-voting on shares	Click here to vote

Key Management of SpyGlass Pharma, Inc.

Name	Title
Dr. Malik Y. Kahook M.D.	Co-Founder, President, Chief Medical Officer & Executive Chairman
Dr. Chetan Pujara Ph.D.	Chief Research & Development Officer
Mr. James Robert Dennewill Jr.	Chief Operating Officer
Ms. Rachel Gilette	Vice President of Human Resources
Mr. Patrick H. Mooney	CEO & Director
Mr. Glenn Sussman	Co-founder & Chief Technology Advisor
Dr. Jean-Frederic Viret Ph.D.	Chief Financial Officer
Mr. Paul Yoo O.D.	Senior Vice President of Clinical Development
Ms. Nina Nguyen	Senior Vice President, Regulatory & Quality
Mr. Long Doan	VP & Head of Clinical Operations

FAQs

What is SpyGlass Pharma, Inc. share price today?

SpyGlass Pharma, Inc. share price today is $24.19 as on May 13, 2026 at 1:29 am IST at the close of the market. SpyGlass Pharma, Inc. share today touched a day high of $24.35 and a low of $23.41.

What is the 52 week high and 52 week low for SpyGlass Pharma, Inc. share?

SpyGlass Pharma, Inc. share touched a 52 week high of $ on January 1, 1970 and a 52 week low of $ on January 1, 1970. SpyGlass Pharma, Inc. stock price today i.e. May 13, 2026 at 1:29 am IST is closed at $24.19,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is SpyGlass Pharma, Inc.'s market capitalisation today?

SpyGlass Pharma, Inc. market capitalisation is $0.00T as on May 13, 2026 at 1:29 am IST.

How to invest in SpyGlass Pharma, Inc. Stock (SGP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for SpyGlass Pharma, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in SpyGlass Pharma, Inc. Shares that will get you 0.0620 shares as per SpyGlass Pharma, Inc. share price of $24.19 per share as on May 13, 2026 at 1:29 am IST.

What is the minimum amount required to buy SpyGlass Pharma, Inc. Stock (SGP) from India?

Indian investors can start investing in SpyGlass Pharma, Inc. (SGP) shares with as little as ₹95.618 or $1 (as of May 13, 2026 at 6:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹956.18 in SpyGlass Pharma, Inc. stock (as per the Rupee-Dollar exchange rate as on May 13, 2026 at 6:41 am IST). Based on SpyGlass Pharma, Inc. share’s latest price of $24.19 as on May 13, 2026 at 1:29 am IST, you will get 0.4134 shares of SpyGlass Pharma, Inc.. Learn more about fractional shares .